➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Mallinckrodt
Boehringer Ingelheim
Dow
Baxter

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

Details for Biologics License Application: 761115


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for BLA: 761115
Tradename:TRODELVY
Applicant:Immunomedics, Inc.
Ingredient:sacituzumab govitecan
Patents:9
Approval Date:Apr 22, 2020
Suppliers: see list1

US Patents for BLA: 761115

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Immunomedics Inc TRODELVY sacituzumab govitecan-hziy INJECTABLE;INJECTION 761115 001 2020-04-22   Start Trial Immunomedics, Inc. (Morris Plains, NJ) 2032-12-13 RX search
Immunomedics Inc TRODELVY sacituzumab govitecan-hziy INJECTABLE;INJECTION 761115 001 2020-04-22   Start Trial Immunomedics, Inc. (Morris Plains, NJ) 2032-12-13 RX search
Immunomedics Inc TRODELVY sacituzumab govitecan-hziy INJECTABLE;INJECTION 761115 001 2020-04-22   Start Trial Immunomedics, Inc. (Morris Plains, NJ) 2032-12-13 RX search
Immunomedics Inc TRODELVY sacituzumab govitecan-hziy INJECTABLE;INJECTION 761115 001 2020-04-22   Start Trial Immunomedics, Inc. (Morris Plains, NJ) 2035-06-25 RX search
Immunomedics Inc TRODELVY sacituzumab govitecan-hziy INJECTABLE;INJECTION 761115 001 2020-04-22   Start Trial Immunomedics, Inc. (Morris Plains, NJ) 2032-12-13 RX search
Immunomedics Inc TRODELVY sacituzumab govitecan-hziy INJECTABLE;INJECTION 761115 001 2020-04-22   Start Trial THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, CA) 2035-09-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Harvard Business School
Baxter
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.